drugset
drugset / Trial / NCT02140281

To Assess the Effect of AZD1722 on the Pharmacokinetics of Cefadroxil in Healthy Volunteers

NCT02140281 ↗

Phase 1 Completed 71 enrolled Ardelyx
RandomizedCrossoverOpen-labelBasic science

Summary

A study to evaluate the effect of repeated oral doses of AZD1722 on the pharmacokinetics of Cefadroxil

Timeline

Start
2014-05
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefadroxil Small molecule 500 mg Oral
Subject Tenapanor Small molecule 15 mg Oral

Indications

No indication recorded.